Editorial: Immuno-diagnosis of active tuberculosis; are we making progress?

• Harriet Mayanja-Kizza,
• Harriet Mayanja-Kizza,
• Pere-Joan Cardona,
• Pere-Joan Cardona,
• Pere-Joan Cardona,
• Pere-Joan Cardona,
• Novel N. Chegou,
• Novel N. Chegou

Affiliations

Harriet Mayanja-Kizza

Makerere University, Kampala, Uganda

Harriet Mayanja-Kizza

Uganda CWRU Research Collaboration, Kampala, Uganda

Pere-Joan Cardona

Department of Microbiology, University of Barcelona, Barcelona, Spain

Pere-Joan Cardona

Microbiology Department, North Metropolitan Clinical Laboratory, ‘Germans Trias i Pujol’ University Hospital, Badalona, Catalonia, Spain

Pere-Joan Cardona

Genetics and Microbiology Department, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Catalonia, Spain

Pere-Joan Cardona

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain

Novel N. Chegou

DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research South African Medical Research Council Centre for Tuberculosis Research, Cape Town, South Africa

Novel N. Chegou

Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa